---
title: "HTG Molecular Diagnostics, Inc. (HTGMQ.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/HTGMQ.US.md"
symbol: "HTGMQ.US"
name: "HTG Molecular Diagnostics, Inc."
industry: "Health Care Technology"
---

# HTG Molecular Diagnostics, Inc. (HTGMQ.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Technology |
| Location | US Market |
| Website | [www.htgmolecular.com](https://www.htgmolecular.com) |

## Company Profile

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG E...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:14.000Z

**Overall: E (0.84)**

**Industry**: Health Care Technology

| Metric | Value |
|--------|-------|
| Industry Ranking | 47 / 47 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -28.21% |  |
| Net Profit YoY | -7.22% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.21 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 6.21M |  |


**Multi Score**: E

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -343.21% | E |
| Profit Margin | -324.28% | E |
| Gross Margin | -167.52% | E |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -28.21% | E |
| Net Profit YoY | -7.22% | C |
| Total Assets YoY | -61.83% | E |
| Net Assets YoY | -95.79% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -30.84% | D |
| OCF YoY | -28.21% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.32 | D |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 95.63% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - HTG Molecular Diagnostics, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-343.21%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-324.28%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-167.52%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-28.21%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-7.22%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-61.83%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-95.79%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-30.84%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-28.21%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.32",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "95.63%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B |
| 02 | Waystar (US.WAY) | C | A | D | B | B | B |
| 03 | Doximity (US.DOCS) | A | B | C | A | C | B |
| 04 | Phreesia (US.PHR) | C | B | A | B | D | B |
| 05 | HealthStream (US.HSTM) | B | C | B | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/HTGMQ.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/HTGMQ.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/HTGMQ.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.